Additional Info
via WikipediaOn the Blogs
In the News
-
Cell Therapeutics, AstraZeneca lead drug stocks
MarketWatch 9 hours, 27 minutes ago... shares of Cell Therapeutics bounced back after diving almost 25% on Monday over concerns about its new non-Hodgkin's lymphoma treatment pixantrone. ...
-
Low-dose radiation for Hodgkin's lymphoma leaves kids at high risk for second ...
Curetoday.com (press release) 2 hours, 19 minutes agoIn a February 1 online paper in the Journal of Clinical Oncology, she and her colleagues report on 110 pediatric Hodgkin's lymphoma survivors who received ...
Loading More Stories